Wolfgang Melchinger

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 289 citations · Full text

Medicine, Immunology, Oncology +7

Oncogenic JAK2 ^V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann et al. · Science Translational Medicine · 2018 · 224 citations

Medicine, Immunology, Oncology +17

Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

Franziska Maria Uhl, Sophia Chen, David O’Sullivan et al. · Science Translational Medicine · 2020 · 131 citations · Full text

Life Sciences, Biochemistry, Oncology +17

MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation

Natalie Stickel, Kathrin Hanke, Dominik Marschner et al. · Leukemia · 2017 · 124 citations

Life Sciences, Genetics, Immunology +16

miR-146a Controls Immune Response in the Melanoma Microenvironment

Justin Mastroianni, Natalie Stickel, Hana Andrlová et al. · Cancer Research · 2018 · 105 citations · Full text

Medicine, Immunology, Oncology +17